The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WANdisco secures credit facility with HSBC

5 Aug 2014 07:00

RNS Number : 2245O
WANdisco Plc
05 August 2014
 

 

 

 

5 August 2014

WANdisco plc

 

WANdisco secures credit facility with HSBC

$10m committed debt funding to finance company expansion

 

London, UK - WANdisco plc (LSE: WAND, "WANdisco"), has agreed a $10m revolving credit facility with HSBC Bank plc ("HSBC"), available until 31 March 2017.

 

The funds available through the facility will be used to finance WANdisco's continued expansion in the Big Data market, including product development and go-to-market activities.

The interest rate on funds drawn down under the facility will be 1.2% above the prevailing LIBOR interest rate.

Paul Harrison, WANdisco Chief Financial Officer, commented: "I am pleased that HSBC has committed this credit facility to WANdisco. The reliability, predictability and high growth potential of our subscription-based business model enabled us to secure this credit facility on attractive terms. HSBC's involvement, alongside our equity investors, diversifies our financing options as we expand in the Big Data marketplace, a marketplace that is attracting corporate investments on a significant scale."

HSBC's evaluation concluded that WANdisco represents an attractive lending proposition, linked to a significant market opportunity in the rapidly evolving Big Data market.

HSBC Head of Corporate Banking in the UK, Dan Howlett, added: "I am delighted that we have taken this opportunity to support WANdisco. We were sufficiently impressed with the company's growth prospects to make a commitment at investment-grade interest rates. This transaction shows our support for emerging technology - a market we consider to have high potential."

 

For further information please contact:

 

WANdisco plc

via FTI Consulting LLP

David Richards, Chief Executive Officer

Paul Harrison, Chief Financial Officer

Phil Branston, VP Corporate Development and Investor Relations

 

FTI Consulting LLP

+44 (0)20 3727 1000

Matt Dixon / Sophie McMillan / Jon Snowball / Roger Newby

 

Investec Bank plc (Joint Broker and Nominated Adviser)

+44 (0)20 7597 4000

Christopher Baird / Dominic Emery

 

UBS Investment Bank (Joint Broker)

+44 (0)20 7568 8000

Rahul Luthra / Sandip Dhillon

 

 

 

 

About WANdisco

WANdisco (LSE: WAND) is a provider of enterprise-ready, non-stop software solutions that enable globally distributed organizations to meet today's data challenges of secure storage, scalability and availability. WANdisco's products are differentiated by the company's patented, active-active data replication technology, serving crucial high availability (HA) requirements, including Hadoop Big Data and Application Lifecycle Management (ALM), including Apache Subversion and Git. Fortune Global 1000 companies, including Juniper Networks, Motorola, Intel and Halliburton, rely on WANdisco for performance, reliability, security and availability. For additional information, please visit www.wandisco.com.

 

About HSBC Corporate Banking

HSBC is one of the world's largest banking and financial services organisations with more than 6,300 offices and 54 million customers worldwide. HSBC Corporate Banking provides funding, risk management, corporate finance advisory, and international services.

 

Ends

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFVRTIISIIS
Date   Source Headline
4th Oct 20237:00 amRNSWANdisco plc rebrands as Cirata plc
22nd Sep 20236:24 pmRNSHolding(s) in Company
11th Sep 20237:00 amRNSInterim results
7th Sep 20233:30 pmRNSNotice of Results
30th Aug 20236:04 pmRNSResult of Annual General Meeting
18th Aug 20236:05 pmRNSBlock Admission Notification
16th Aug 20238:07 amRNSGM Signs Multi-Project Contract with WANdisco
31st Jul 20237:00 amRNSHolding(s) in Company
28th Jul 20233:25 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSBoard Changes
25th Jul 20237:30 amRNSRestoration - WANdisco plc
25th Jul 20237:00 amRNSConfirmation of Exchange Rate
24th Jul 202310:45 amRNSResult of GM
17th Jul 20235:00 pmRNSPosting of Annual Report and Accounts
12th Jul 20231:45 pmRNSPublication of Annual Report and Accounts
11th Jul 20237:00 amRNSContract Win
10th Jul 20237:00 amRNSContract Renewal
7th Jul 20237:00 amRNSConfirmation of Fundraise
5th Jul 20236:29 pmRNSPublication of Notice of General Meeting
5th Jul 202311:30 amRNSUpdate to Fundraise Timetable
4th Jul 20237:00 amRNSResult of Fundraising
3rd Jul 202312:00 pmRNSLaunch of Fundraise
29th Jun 20237:00 amRNSPreliminary Unaudited Results FY22
28th Jun 202311:51 amRNSUpdate on Timing of Results and Equity Issue
26th Jun 20233:30 pmRNSTurnaround Plan Momentum
26th Jun 20237:00 amRNSWANdisco Signs New Agreement with Accenture
15th Jun 20239:46 amRNSFCA investigation timeline update
9th Jun 20237:00 amRNSSuccessful Shareholder General Meeting Next Steps
6th Jun 20233:49 pmRNSResult of General Meeting
19th May 20236:22 pmRNSPublication of Circular and Notice of GM
19th May 20236:04 pmRNSBoard Change
15th May 20237:00 amRNSExploring Funding Options
9th May 20235:30 pmRNSWANdisco
9th May 20237:00 amRNSAppointment of Interim Chief Executive
4th May 20237:00 amRNSOrganisation Update
28th Apr 20237:00 amRNSIndependent Investigation Update
20th Apr 20237:00 amRNSFCA Investigation
5th Apr 20237:00 amRNSExecutive Chair Appointment Confirmation
4th Apr 20237:00 amRNSContract Renewals
3rd Apr 20237:00 amRNSBoard Change and Investigation Update
22nd Mar 20237:00 amRNSAppointment of Interim Chair
10th Mar 20239:31 amRNSIndependent Investigation Appointment
9th Mar 20237:30 amRNSSuspension - WANdisco plc
9th Mar 20237:00 amRNSTrading Revision
7th Mar 20237:00 amRNSAppointment of Joint Broker
6th Mar 20237:00 amRNSResponse to press speculation
1st Mar 20238:16 amRNSTotal Voting Rights
1st Feb 20234:05 pmRNSTotal Voting Rights
24th Jan 20237:00 amRNS$9m industrial and consumer goods contract win
11th Jan 20237:00 amRNSFY22 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.